Ibritumomab Intravenous and Sinequan (Doxepin Oral Concentrate)
Determining the interaction of Ibritumomab Intravenous and Sinequan (Doxepin Oral Concentrate) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules, Sinequan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Sinex Long-Acting
- Ibritumomab Intravenous-Sinex Nasal Spray
- Ibritumomab Intravenous-Singulair
- Ibritumomab Intravenous-Singulair (Montelukast Chewable Tablets)
- Ibritumomab Intravenous-Singulair (Montelukast Oral Granules)
- Ibritumomab Intravenous-Singulair (Montelukast Tablets)
- Sinequan (Doxepin Oral Concentrate)-Ibritumomab Tiuxetan
- Sinequan (Doxepin Oral Concentrate)-Ibrutinib
- Sinequan (Doxepin Oral Concentrate)-Ibrutinib Capsules
- Sinequan (Doxepin Oral Concentrate)-Ibrutinib Tablets
- Sinequan (Doxepin Oral Concentrate)-Ibu
- Sinequan (Doxepin Oral Concentrate)-IBU Tablets